Form D · Other Health Care
Solace Lifesciences, Inc.
Wilmington, DE · CIK 0001502380
Offering snapshot reported Dec 7, 2018 · SEC filing
- Reported sold
- Yet to sell Offering amount: $5M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 7, 2018 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Dec 14, 2017 | Amendment | $1,551,401 | No comparison | 43 | SEC filing |
| May 1, 2015 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Oct 6, 2010 | Initial | $50,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $350K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-327414
Source: Form D, filed Dec 7, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Allen | Director |
| Christopher G Gross | Director, Executive |
| Garrett Holloway | Director |
| Stephen Kujawa | Director |
| David Pilzner | Director |
| James M Poole | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
501 Silverside Road #7
Wilmington, DE, 19809
Wilmington, DE, 19809